Biocryst Pharmaceuticals buy Needham & Company LLC
Start price
03.08.23
/
50%
€6.47
Target price
03.08.24
€10.96
Performance (%)
-12.53%
Price
24.05.24
€5.66
Summary
This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.53%. This prediction currently runs until 03.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biocryst Pharmaceuticals | -2.179% | -2.179% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Needham___Company_LL for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock, down previously from $14.00.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.98
07.05.24
07.05.24
€11.13
07.05.25
07.05.25
13.60%
24.05.24
24.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.00
08.01.24
08.01.24
€10.95
08.01.25
08.01.25
-5.73%
24.05.24
24.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.70
06.11.23
06.11.23
€11.17
06.11.24
06.11.24
-0.77%
24.05.24
24.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€12.77
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24